India’s pathology sector is transforming rapidly, with the diagnostic industry expected to grow from $10 billion in 2021 to $20 billion by 2026, a 14% annual increase. This growth is driven by rising demand for quality healthcare, technological advancements, and increased awareness of early diagnosis. However, the industry faces challenges due to its fragmentation, with over 100,000 labs varying in quality and scalability. This fragmentation complicates standardisation but also offers opportunities for innovative models. Specialised tests and AI adoption are boosting diagnostic accuracy and customer experience, yet rural areas still lack accredited labs, underscoring the need for more qualified pathologists and better service distribution.
Since its establishment in 2016, Pathkind Labs has led Indian diagnostics, operating 70 labs and over 2000 centres nationwide. Accredited by NABL and NABH, it ensures high-quality standards, earning trust from patients and healthcare professionals. Pathkind Labs integrates advanced technology, including AI, to enhance diagnostic accuracy and efficiency. Its extensive service range covers routine and specialised tests, catering to diverse healthcare needs. With a patient-centric approach, including home collection services, Pathkind Labs prioritises convenience and accessibility. Under the leadership of Dr. Deepa Dave, the company continues to innovate and expand, significantly impacting public health.
At the helm of Pathkind Labs’ operational success is Dr. Deepa, the National Director of Operations. Dr. Deepa’s illustrious career in the diagnostic industry spans 28 years, marked by significant contributions and leadership roles. She holds an MBBS and an MD from Lady Hardinge Medical College, credentials that reflect her profound expertise in the field. Her areas of specialisation include haematology, immunohaematology, coagulation, and flow cytometry, which have been instrumental in driving Pathkind Labs towards excellence.
Before joining Pathkind Labs, Dr. Deepa spent over 15 years with SRL Diagnostics, where she played a crucial role in establishing and managing over 300 laboratories across India. Her tenure at SRL Diagnostics not only honed her leadership skills but also equipped her with a deep understanding of the industry’s complexities. This experience laid a strong foundation for her current role at Pathkind Labs, where she continues to influence the diagnostic landscape significantly.
Under Dr. Deepa’s leadership, Pathkind Labs has embraced a patient-centric approach that prioritises patient care outcomes and convenience. One of the notable initiatives is the introduction of home collection services, which ensures that patients can access diagnostic services from the comfort of their homes, especially during emergencies. This initiative aligns with the broader industry trend of patient-centred business models, enhancing patient satisfaction and trust.
Dr. Deepa’s vision for Pathkind Labs is clear and forward-thinking: to provide accurate and timely diagnostics that play a crucial role in patient care. Her mission revolves around ensuring that every patient receives reliable diagnostic services, thereby improving overall healthcare outcomes. Her work ethic emphasises accuracy, precision, and a relentless focus on quality—principles that have become synonymous with Pathkind Labs.
As the National Director of Operations, Dr. Deepa is not just focused on the present but is also steering Pathkind Labs towards a future where diagnostics are more integrated with advanced technologies like artificial intelligence (AI). AI’s potential in pathology, particularly in enhancing diagnostic accuracy and efficiency, is vast. Dr. Deepa’s forward-thinking approach ensures that Pathkind Labs remains at the forefront of technological adoption, ready to meet the industry’s future demands.
AI and digital pathology are set to revolutionise the diagnostic landscape by improving the accuracy of test results and the speed of diagnosis. Dr. Deepa recognises the importance of integrating these technologies to enhance the quality and efficiency of diagnostics. Her commitment to innovation ensures that Pathkind Labs is well-positioned to leverage these advancements for better patient outcomes.
Dr. Deepa’s leadership at Pathkind Labs is a beacon of transformation in India’s diagnostic landscape. Her extensive experience, coupled with her commitment to quality and innovation, has positioned Pathkind Labs as a leader in providing accessible, reliable, and advanced diagnostic services. As the industry continues to evolve, Dr. Deepa’s contributions will undoubtedly play a pivotal role in shaping the future of pathology in India. Through her vision and dedication, Pathkind Labs is set to continue its trajectory of growth and excellence, ultimately improving healthcare outcomes for millions of patients across the country.
